On April 18, 2026, President Donald Trump issued an executive directive instructing federal agencies to fast-track studies of ibogaine, a psychedelic substance that could help veterans battling post-traumatic stress disorder and related mental health challenges.
The executive action targets ibogaine, a Schedule I controlled substance extracted from an African plant, which researchers believe may effectively treat PTSD, brain injuries from trauma, depression, anxiety, thoughts of self-harm, and addiction to opioids. The directive commands federal departments to eliminate bureaucratic obstacles hampering research progress, enhance inter-agency collaboration and information sharing, and make clinical testing a top priority.
The Food and Drug Administration has been assigned responsibility for creating secure treatment guidelines under this new policy, while roughly $50 million in fresh federal resources will fund ibogaine and similar psychedelic studies. Officials anticipate government-approved therapeutic programs could launch by the summer of 2026.
“I’ve always believed in ensuring that the American patients have access to breakthrough treatments and therapies … Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life. They’ve been through so much,” President Trump said during the signing.
The executive order has garnered backing from military veteran organizations, media personality Joe Rogan, former Texas Governor Rick Perry, and Representative Dan Crenshaw, who stated he knows individuals who remain alive today due to ibogaine treatment. Dr. Mehmet Oz characterized the decision as “an entire paradigm shift away from a one-pill-a-day model, which has failed so many.”
This policy change emerges amid persistent struggles with veteran mental health issues, as government data shows over 6,000 military veterans take their own lives annually, while millions of Americans continue battling mental health conditions that resist conventional treatment methods.
